EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Antibiotic Susceptibility Patterns of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales (ESBL-E), Tennessee 2019–2024

Sarah Petersen, Daniel Muleta, Christopher Evans, Cherlly Bailey, Carissa Wallace, Becky Meyer

Antimicrobial Stewardship & Healthcare Epidemiology · 2026-08 · 6 (S1) · s111-s112

DOI: 10.1017/ash.2026.10606 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antimicrobial Stewardship & Healthcare Epidemiology, online erschienen am 23.06.2026. Verfasst von Sarah Petersen und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Extended-spectrum beta-lactamase-producing Enterobacterales (ESBL-E) are a growing public health concern. This study investigates antibiotic resistance patterns for ESBL-E (Escherichia coli and Klebsiella species) cases in Maury and surrounding counties in Tennessee as part of the Emerging Infection Program’s Multi-site Gram-negative Surveillance Initiative.

Methods

ESBL-E cases are defined as extended-spectrum cephalosporin-resistant E. coli, Klebsiella pneumoniae, Klebsiella variicola, or Klebsiella oxytoca isolated from urine or normally sterile sites from residents of the surveillance area. Cases from July 2019 through December 2024 were included. Susceptibility data were collected from clinical laboratory reports. E. coli isolate resistance was compared to aggregated Klebsiella species isolate resistance using χ or fisher’s exact tests. Organism specific yearly resistance trends excluded the incomplete 2019 collection year and were examined via simple linear regression. Analyses were performed in SAS 9.4.

Results

We identified 2,206 isolates including 1,915 E. coli isolates, of which 1,868 (97.5%) were from urine, and 291 Klebsiella isolates, of which 281 (96.6%) were from urine. Overall percent resistance for selected antibiotics were as follows: ciprofloxacin: 69.0%, levofloxacin: 64.3%, cefepime: 81.1%, cefazolin: 98.7%, cefotaxime: 85.9%, ceftazidime: 53.2%, ceftriaxone: 92.8%, piperacillin-tazobactam: 2.6%, nitrofurantoin: 9.0%, trimethoprim-sulfamethoxazole: 57.8%. During the study period, E. coli isolates displayed increased resistance to cefepime (3.0% per year, P

Zitieren

APA

Petersen, S., Muleta, D., Evans, C., Bailey, C., Wallace, C., & Meyer, B. (2026). Antibiotic Susceptibility Patterns of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales (ESBL-E), Tennessee 2019–2024. Antimicrobial Stewardship & Healthcare Epidemiology, 6(S1), s111-s112. https://doi.org/10.1017/ash.2026.10606

Vancouver

Petersen S, Muleta D, Evans C, Bailey C, Wallace C, Meyer B. Antibiotic Susceptibility Patterns of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales (ESBL-E), Tennessee 2019–2024. Antimicrobial Stewardship & Healthcare Epidemiology. 2026;6(S1):s111-s112. doi:10.1017/ash.2026.10606

BibTeX
@article{Petersen2026,
  author = {Petersen, Sarah and Muleta, Daniel and Evans, Christopher and Bailey, Cherlly and Wallace, Carissa and Meyer, Becky},
  title = {Antibiotic Susceptibility Patterns of Extended-Spectrum Beta-Lactamase-Producing Enterobacterales (ESBL-E), Tennessee 2019–2024},
  journal = {Antimicrobial Stewardship & Healthcare Epidemiology},
  year = {2026},
  volume = {6},
  number = {S1},
  pages = {s111--s112},
  doi = {10.1017/ash.2026.10606}
}
Kostenlos starten →